Literature DB >> 12899469

Image quality in myopic eyes corrected with laser in situ keratomileusis and phakic intraocular lens.

Edwin J Sarver1, Donald R Sanders, John A Vukich.   

Abstract

PURPOSE: To compare image quality due to higher-order aberrations following laser in situ keratomileusis (LASIK) or implantation of phakic intraocular lens (PIOL) to correct high myopia.
METHODS: Postoperative wavefront examinations, normalized to a pupil size of 5.5 mm, were obtained for 19 LASIK and 20 PIOL eyes for the same surgeon over the same time period. Higher-order aberrations and simulated retinal images were compared.
RESULTS: For this small sample, the LASIK eyes yielded an average three times more spherical aberration and two times more coma than PIOL eyes. The effects of these differences were visualized using the simulated retinal images.
CONCLUSION: Spherical aberration and coma are the major differences between postoperative LASIK and PIOL higher-order aberrations, and simulated retinal images can be used to visualize these effects.

Entities:  

Mesh:

Year:  2003        PMID: 12899469     DOI: 10.3928/1081-597X-20030701-04

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  11 in total

1.  [Higher order aberrations after implantation of an iris claw pIOL (Ophtec Artisan) in the phakic eye].

Authors:  J Bühren; T Kasper; E Terzi; T Kohnen
Journal:  Ophthalmologe       Date:  2004-12       Impact factor: 1.059

Review 2.  [Application of wavefront analysis in clinical and scientific settings. From irregular astigmatism to aberrations of a higher order--Part II: examples].

Authors:  J Bühren; T Kohnen
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

3.  Correction of high myopia with different phakic anterior chamber intraocular lenses: ICARE angle-supported lens and Verisyse iris-claw lens.

Authors:  Stanislawa Gierek-Ciaciura; Ariadna Gierek-Lapinska; Krzysztof Ochalik; Ewa Mrukwa-Kominek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-07-01       Impact factor: 3.117

4.  Optical quality of the Visian Implantable Collamer Lens for different refractive powers.

Authors:  Cari Pérez-Vives; Alberto Domínguez-Vicent; Teresa Ferrer-Blasco; Álvaro M Pons; Robert Montés-Micó
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-11       Impact factor: 3.117

Review 5.  The posterior chamber phakic refractive lens (PRL): a review.

Authors:  R J Pérez-Cambrodí; D P Piñero; T Ferrer-Blasco; A Cerviño; R Brautaset
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

6.  Five-year follow-up after anterior iris-fixated intraocular lens implantation in phakic eyes to correct high myopia.

Authors:  X Yuan; H Z Ping; W C Hong; D Yin; Z Ting
Journal:  Eye (Lond)       Date:  2011-12-02       Impact factor: 3.775

7.  Outcomes and possible risk factors associated with axis alignment and rotational stability after implantation of the Toric implantable collamer lens for high myopic astigmatism.

Authors:  Xun-Lun Sheng; Wei-Ning Rong; Qin Jia; Ya-Ni Liu; Wen-Juan Zhuang; Qing Gu; Yan Sun; Bo Pan; De-Jun Zhu
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

8.  Comparison of clear lens extraction and collamer lens implantation in high myopia.

Authors:  Ahmed M Emarah; Mostafa A El-Helw; Hazem M Yassin
Journal:  Clin Ophthalmol       Date:  2010-05-14

9.  Comparison of three phakic intraocular lenses for correction of myopia.

Authors:  Farid Karimian; Alireza Baradaran-Rafii; Seyed Javad Hashemian; Ali Hashemloo; Mohammad Ebrahim Jafari; Mehdi Yaseri; Elham Ghahari; Shadi Akbarian
Journal:  J Ophthalmic Vis Res       Date:  2014 Oct-Dec

10.  Ocular higher-order aberrations changes after implantable collamer lens implantation for high myopic astigmatism.

Authors:  Seyed Javad Hashemian; Hosein Farrokhi; Alireza Foroutan; Mohammad Ebrahim Jafari; Seyed Mahyar Hashemian; Sayyed Amirpooya Alemzadeh; Mahsa Sadat Hashemian
Journal:  J Curr Ophthalmol       Date:  2017-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.